Chimerix's average Accounts Receivable for the
three
months ended in Dec. 2024 was $0.11 Mil. Chimerix's Revenue for the
three
months ended in Dec. 2024 was $0.06 Mil.
Hence, Chimerix's Days Sales Outstanding for the
three
months ended in Dec. 2024 was 169.69.
The historical rank and industry rank for Chimerix's Days Sales Outstanding or its related term are showing as below:
CMRX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.22 Med: 52.98 Max: 588.06
Current: 119.14
During the past 13 years, Chimerix's highest Days Sales Outstanding was 588.06. The lowest was 11.22. And the median was 52.98.
CMRX's Days Sales Outstanding is ranked worse than 74.62% of 847
companies
in the Biotechnology industry
Industry Median: 72.45
vs CMRX: 119.14
Chimerix's Days Sales Outstanding
declined
from Dec. 2023 (171.09) to Dec. 2024 (169.69).
Chimerix Days Sales Outstanding Historical Data
The historical data trend for Chimerix's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Chimerix's Days Sales Outstanding
For the Biotechnology subindustry, Chimerix's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chimerix's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chimerix's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Chimerix's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chimerix (NAS:CMRX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Chimerix Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Chimerix's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CMRX has been successfully added to your 